| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 04/13/1993 | US5202349 Substituted phenylacetylenes, pharmaceutical compositions containing these compounds and processes for the preparation of these compounds and compositions |
| 04/13/1993 | US5202321 Antihistamine, antiallergens, antiinflammatory agents |
| 04/13/1993 | US5202312 Antiarthritic agents, antiallergens, antidiabetic agents |
| 04/13/1993 | US5202119 Administering somatomedins |
| 04/12/1993 | WO1993007118A1 9-substituted bicyclo[3.3.0]octane derivatives, for use as txa2 antagonists |
| 04/12/1993 | CA2097930A1 9-substituted bicyclo[3.3.0]octane derivatives, for use as txa2 antagonists |
| 04/12/1993 | CA2080258A1 Process for the purification of streptolysin o, intact streptolysin o obtainable by this process and its use |
| 04/10/1993 | CA2079428A1 Pharmaceutical compounds |
| 04/09/1993 | CA2079938A1 Solid formulation containing amide derivative and method of manufacturing the formulation |
| 04/07/1993 | EP0535926A1 (Hetero-arylmethoxy) indoles as inhibitors of leukotriene biosynthesis |
| 04/07/1993 | EP0535925A1 (Bicyclic-hetero-arylmethoxy)indoles as inhibitors of leukotriene biosynthesis |
| 04/07/1993 | EP0535924A1 (Bicyclic-azaarylmethoxy)indoles as inhibitors of leukotriene biosynthesis |
| 04/07/1993 | EP0535923A1 (Azaarylmethoxy)indoles as inhibitors of leukotriene biosynthesis |
| 04/07/1993 | EP0535521A2 Condensed oxazole and thiazole derivatives as leukotriene biosynthesis inhibitors |
| 04/07/1993 | EP0535250A1 Novel compounds and use thereof as medicine |
| 04/07/1993 | EP0535021A1 Association between a human immunodeficiency virus-related retrovirus and sjogren's syndrome |
| 04/07/1993 | EP0532674A4 Leukotriene antagonists |
| 04/07/1993 | CN1070637A 3-cycloalkyl-prop-2-enamide derivatives |
| 04/06/1993 | US5200553 Biologically active carboxylic acid esters |
| 04/06/1993 | US5200397 Administering an oligopeptides anticoagulants or wound healing agents |
| 04/06/1993 | CA1315686C Pharmaceutical compositions containing at least one naphtylaromatic compound as an active ingredient |
| 04/06/1993 | CA1315685C Pharmaceutical compositions based on benzoic benzopyranyl and benzothiopyranyl compounds |
| 04/06/1993 | CA1315678C Alpha-tocopherol based vesicles |
| 04/01/1993 | WO1993006228A1 A new form of liposaccharide binding protein (lbp) |
| 04/01/1993 | WO1993006135A1 Diagnosing and treating autoimmune disorders |
| 04/01/1993 | WO1993006126A1 Immunoreactive hepatitis c virus polypeptide compositions |
| 04/01/1993 | WO1993006109A1 THIADIAZOLO[4,3-a]PYRIDINE DERIVATIVES, METHODS OF PREPARING THEM AND DRUGS CONTAINING THEM |
| 04/01/1993 | WO1993006085A1 Pyridine compounds for treating leukotriene-related diseases |
| 04/01/1993 | WO1993005813A1 Method of producing antibodies to a restricted population of t lymphocytes, antibodies and method of use |
| 04/01/1993 | WO1993005810A1 VACCINE COMPRISING PART OF CONSTANT REGION OF IgE FOR TREATMENT OF IgE-MEDIATED ALLERGIC REACTIONS |
| 04/01/1993 | WO1993005806A1 Composition and method of treating hepatitis c |
| 04/01/1993 | WO1993005797A1 Compositions comprising a bactericidal/permeability increasing protein and a lipid carrier, methods of making same, and uses thereof |
| 04/01/1993 | WO1993005781A1 Novel alpha-mannosidase inhibitors |
| 04/01/1993 | CA2120036A1 Method of producing antibodies to a restricted population of t lymphocytes, antibodies produced therefrom and methods of use thereof |
| 04/01/1993 | CA2119467A1 Pyridine compounds for treating leukotriene-related diseases |
| 04/01/1993 | CA2118574A1 Thiadiazolo [4,3-a]pyridine derivatives, processes for their preparation and medicaments containing these |
| 03/31/1993 | EP0534878A1 Recombinant DNA molecules containing the coding part of a VBeta17 chain of the T cell antigen receptor and uses thereof |
| 03/31/1993 | EP0533865A1 Peat-derived bioactive products and pharmaceutical and cosmetic compositions containing them |
| 03/31/1993 | CN1070404A Heterocyclic derivatives |
| 03/30/1993 | US5198567 Benzonorbornene derivatives, processes for their preparation and medicinal and cosmetic compositions containing them |
| 03/30/1993 | US5198552 Indole derivative having antiviral, interferon-inducing and immunomodulatory effects |
| 03/30/1993 | US5198334 Protection of natural killer cell cytolytic activity in peripheral blood mononuclear cells |
| 03/30/1993 | CA1315478C Tripeptide with immunostimulating activity |
| 03/30/1993 | CA1315472C Thymopentin retro-inverso analogs and fragments thereof, a process of preparation of the new compounds and the intermediates obtained therein |
| 03/30/1993 | CA1315471C Pyridine-2,4- and 2,5-dicarboxylic acid derivatives, a process for their preparation, the use thereof, and medicaments based on these compounds |
| 03/30/1993 | CA1315227C Immunosuppressant-producing culture |
| 03/30/1993 | CA1315225C Polypeptide useful for the allevation, treatment and diagnosis of auto-immune diseases, especially arthritic conditions, etc. |
| 03/27/1993 | CA2079197A1 Recombinant nda new molecules containing the codifying part of a vbeta 17 chain for the t-cells antigene receptor, preparat ion process, antibodies and drugs containing them |
| 03/25/1993 | DE4131579A1 Thiadiazolo(4,3-a)pyridinderivate, verfahren zu ihrer herstellung und diese enthaltenden arzneimittel Thiadiazolo (4,3-a) pyridine derivatives, process for their production and containing this drug |
| 03/25/1993 | CA2078810A1 Leukotriene biosynthesis inhibitors |
| 03/24/1993 | EP0533573A2 Derivatives of 3-cyclo alkyl-propen-2-amide, their tautomeres and salts and their use as antiinflammatory agents |
| 03/24/1993 | EP0533433A1 Use of rapamycin for the manufacture of a medicament for the treatment of immunoinflammatory diseases |
| 03/24/1993 | EP0533342A1 Anti-HIV (AIDS) agents |
| 03/24/1993 | EP0533226A2 Novel chromophore containing compounds |
| 03/24/1993 | EP0533210A1 Protein C containing pharmaceutical preparations |
| 03/24/1993 | EP0533209A1 beta-sympathomimetic Protein C containing pharmaceutical preparation |
| 03/24/1993 | EP0533130A1 2-Hydroxymethylpyridines, the corresponding pyridine-N-oxides and derivatives thereof, process for their preparation and their use |
| 03/24/1993 | EP0532979A2 Peptides for the preparation of means for diagnosis and therapy of systemic lupus |
| 03/24/1993 | EP0532716A1 New synthethic peptides with imunomodulating activity and preparation thereof |
| 03/24/1993 | EP0532674A1 Leukotriene antagonists |
| 03/24/1993 | EP0532531A1 Phenol and pyridinol derivatives as pharmaceuticals |
| 03/24/1993 | EP0532530A1 Derivatives of 6-aminooctahydroindolizinetriol. |
| 03/24/1993 | CN1070190A Heterocyclically substituted quinolylmethoxy-phenylacetamides |
| 03/23/1993 | US5196570 Leukotriene-b4 derivatives, process for their production and their use as pharmaceutical agents |
| 03/23/1993 | US5196445 Heteroaryl-3-oxo-propanenitrile derivatives useful in the treatment of rheumatoid arthritis and other autoimmune diseases |
| 03/23/1993 | US5196402 S-adenosyl-methionine in the treatment of pancreatitis and of the immuno rejection in the pancreas transplant |
| 03/23/1993 | US5196319 Primary biliary cirrhosis autoantigen |
| 03/23/1993 | CA1314899C2 Epoxides |
| 03/23/1993 | CA1314891C Acetylenes disubstituted with a phenyl group and a heterobicyclic group having retinoid like activity |
| 03/23/1993 | CA1314889C Glycerol derivatives, their preparation and their therapeutic use |
| 03/23/1993 | CA1314879C Anellated indole derivatives |
| 03/23/1993 | CA1314877C N-acetyl-3-fluoro-neuraminic acid derivatives and preparation thereof |
| 03/20/1993 | CA2078590A1 2-hydroxymethylpyridines, the corresponding pyridine n-oxides and their derivatives, processes for their preparation and their use |
| 03/18/1993 | WO1993005072A1 Disease associated human autoantibodies specific for human thyroid peroxidase |
| 03/18/1993 | WO1993005071A1 INTERLEUKIN 1β PROTEASE AND INTERLEUKIN 1β PROTEASE INHIBITORS |
| 03/18/1993 | WO1993005059A1 Imidazolidyl macrolides |
| 03/18/1993 | WO1993005058A1 O-heteroaryl, o-alkylheteroaryl, o-alkenylheteroaryl and o-alkynylheteroarylmacrolides |
| 03/18/1993 | WO1993005055A1 Novel sphingoglycolipid and use thereof |
| 03/18/1993 | WO1993005034A1 Bicyclic sulphones, process for producing the same and medicaments containing the same |
| 03/18/1993 | WO1993005026A1 Peptide isoters containing a heterocycle as h.i.v. inhibitors |
| 03/18/1993 | WO1993005020A1 Indoles as inhibitors of hiv reverse transcriptase |
| 03/18/1993 | WO1993005014A1 Aromatic sulfonamide derivatives, their use as enzyme inhibitors and pharmaceutical compositions containing them |
| 03/18/1993 | WO1993004680A1 Macrocyclic immunomodulators |
| 03/18/1993 | CA2116453A1 Disease associated human autoantibodies specific for human thyroid peroxidase |
| 03/18/1993 | CA2116229A1 Bicyclic sulfones, processes for their production and pharmaceutical agents containing them |
| 03/17/1993 | EP0532239A1 Benzenesulphonamide derivatives as 5-lipoxygenase inhibitors |
| 03/17/1993 | EP0532091A1 4-(4-(4-(4-hydroxyphenyl)-1-piperazinyl)-phenyl)-5-methyl-3H-1,2,4-triazol-3-one derivatives as 5-lipoxygenase inhibitors |
| 03/17/1993 | EP0532089A1 N-heteroaryl, N-alkylheteroaryl, N-alkenylheteroaryl & N-alkynylheteroarylmacrolides |
| 03/17/1993 | EP0532088A1 O-Heteroaryl, O-alkylheteroaryl, O-alkenylheteroaryl and O-alkynylheteroaryl macrolides |
| 03/17/1993 | EP0531901A2 Condensed pyrazole derivatives with interleukin-1 and tumour necrosis factor inhibitory activity |
| 03/17/1993 | EP0531823A1 Bicyclic carboxylic acid derivatives as anti-inflammatory agents |
| 03/17/1993 | EP0531598A1 1,4-Dihydropyridines with paf-antagonistic activity |
| 03/17/1993 | CN1069882A Compounds and methods for inhibition of HIV and related viruses |
| 03/17/1993 | CN1020096C Preparation for imidazoline derivatives |
| 03/17/1993 | CN1020095C Process for dichloroaniline derivatives |
| 03/16/1993 | US5194594 Conjugation With Heterobifunctional Reagent, Radionucleotide Label |
| 03/16/1993 | US5194585 Vasoactive peptides |
| 03/16/1993 | US5194448 Use of nervonic acid and long chain fatty acids for the treatment of demyelinating disorders |
| 03/16/1993 | US5194425 Mhc-mediated toxic conjugates useful in ameliorating autoimmunity |
| 03/16/1993 | US5194378 Immunosuppressants |